Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. [electronic resource]
Producer: 20130527Description: 1401-9 p. digitalISSN:- 1879-0844
- Aged
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
- Biomarkers -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Heart Failure -- drug therapy
- Humans
- Losartan -- administration & dosage
- Male
- Middle Aged
- Predictive Value of Tests
- Proportional Hazards Models
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.